Published in Biochim Biophys Acta on December 30, 1994
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J (1995) 4.55
Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer (1999) 2.05
Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A (2001) 1.68
Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br J Cancer (1999) 1.54
Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am J Hum Genet (2003) 1.53
Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer (2009) 1.49
Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am J Pathol (2002) 1.39
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer (1999) 1.17
Estimation of tumor heterogeneity using CGH array data. BMC Bioinformatics (2009) 1.14
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14
Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer (1996) 1.13
Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer (2008) 1.10
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer (1995) 1.06
Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. Mol Med (1998) 1.06
Genetically abnormal clones in histologically normal breast tissue. Am J Pathol (1998) 1.03
Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br J Cancer (1999) 1.01
The long and short of chromosome 11 in breast cancer. Am J Pathol (1998) 0.96
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. Am J Pathol (1998) 0.94
Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol (2001) 0.92
A prognostic index for operable, node-negative breast cancer. Br J Cancer (2004) 0.89
Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer (1997) 0.84
Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers. Br J Cancer (1997) 0.84
Genomic signatures of breast cancer metastasis. Cytogenet Genome Res (2007) 0.84
Allelic Losses from Chromosome 17 in Human Osteosarcomas. Pathol Oncol Res (1997) 0.83
Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. Br J Cancer (1996) 0.80
The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer. Br J Cancer (1999) 0.80
TOP2A amplification and overexpression in hepatocellular carcinoma tissues. Biomed Res Int (2015) 0.80
Gene therapy for carcinoma of the breast: Genetic ablation strategies. Breast Cancer Res (1999) 0.79
Lack of Correlation Between Survival and Allele Loss on Chromosome 7q31-32 in Primary Breast Cancer. Pathol Oncol Res (1996) 0.79
Toward checkmate: biology and breast cancer therapy for the new millennium. Invest New Drugs (1999) 0.78
AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines. BMC Cancer (2006) 0.78
Estimating genomic instability mediated by Alu retroelements in breast cancer. Genet Mol Biol (2009) 0.75
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science (2000) 8.64
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet (1997) 3.68
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem (1993) 3.41
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res (1988) 3.31
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer (2006) 2.74
Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization. Cytogenet Cell Genet (1990) 2.60
Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet (1989) 2.44
Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study. Gut (1980) 2.24
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol (1997) 2.15
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer (1997) 2.02
Ever since Knudson. Trends Genet (2001) 1.96
Two subsets of human alphoid repetitive DNA show distinct preferential localization in the pericentric regions of chromosomes 13, 18, and 21. Cytogenet Cell Genet (1986) 1.90
Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol (1999) 1.81
Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene (1991) 1.81
A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet (1992) 1.80
PCR artifacts in LOH and MSI analysis of microdissected tumor cells. Hum Pathol (2000) 1.77
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res (1988) 1.67
Sequence heterogeneity within the human alphoid repetitive DNA family. Nucleic Acids Res (1986) 1.65
DNA ploidy and survival in breast cancer patients. Cytometry (1987) 1.65
Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer (2000) 1.64
Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol (1991) 1.63
Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Cytometry (1991) 1.57
At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics (1989) 1.55
Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol (1992) 1.55
Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res (1989) 1.55
Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res (1985) 1.53
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res (1992) 1.53
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet (2001) 1.51
At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer (1994) 1.50
[From gene to disease; from BRCA1 or BRCA2 to breast cancer]. Ned Tijdschr Geneeskd (2000) 1.41
Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet (2004) 1.39
Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer (1999) 1.37
Subdivision of S-phase by analysis of nuclear 5-bromodeoxyuridine staining patterns. Cytometry (1989) 1.37
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer (1995) 1.33
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer (2001) 1.32
Diagnostic morphometry of isolated lymph node cells from patients with mycosis fungoides and Sézary's syndrome. Virchows Arch B Cell Pathol Incl Mol Pathol (1980) 1.29
Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol (2007) 1.26
Use of morphometry and immunohistochemistry of small intestinal biopsy specimens in the diagnosis of food allergy. J Clin Pathol (1980) 1.26
Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol (2000) 1.25
Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer (1993) 1.24
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res (2001) 1.23
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res (1994) 1.21
Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period. Ann Otol Rhinol Laryngol (1992) 1.17
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer (1999) 1.17
Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet (1994) 1.14
Confinement of PGL, an imprinted gene causing hereditary paragangliomas, to a 2-cM interval on 11q22-q23 and exclusion of DRD2 and NCAM as candidate genes. Eur J Hum Genet (1996) 1.14
Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity. Br J Cancer (1994) 1.14
Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference. Cytometry (1993) 1.13
Myocardial changes in pressure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation. Eur Heart J (1991) 1.12
Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours. J Pathol (1997) 1.11
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer (2000) 1.10
Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J Pathol (1999) 1.08
Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence. Cytogenet Cell Genet (1990) 1.08
PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer (1993) 1.06
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3. Br J Cancer (1999) 1.06
Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol (2000) 1.05
Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin. Cancer (1980) 1.04
Feasibility of in situ hybridisation with chromosome specific DNA probes on paraffin wax embedded tissue. J Clin Pathol (1991) 1.03
Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement. Anal Quant Cytol (1984) 1.03
Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. Oncogene (1993) 1.03
Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res (1991) 1.02
Direct nonradioactive in situ hybridization of somatic cell hybrid DNA to human lymphocyte chromosomes. Cytometry (1990) 1.02
Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL. Genes Chromosomes Cancer (1994) 1.02
Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group. J Med Genet (1999) 1.02
Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene (1991) 1.01
Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest (1989) 1.01
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23. Hum Genet (1999) 0.98
Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer (1987) 0.98
Malignant lymphoma of true histiocytic origin: histiocytic sarcoma. A morphological, ultrastructural, immunological, cytochemical and clinical study of 10 cases. Virchows Arch A Pathol Anat Histol (1981) 0.97
Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. Eur J Endocrinol (2005) 0.97
The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology (1992) 0.97
DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Breast Cancer Res Treat (1993) 0.97
Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds. Am J Hum Genet (1993) 0.96
Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer (1990) 0.96
Recent developments in the molecular genetic understanding of breast cancer. Crit Rev Oncog (1994) 0.96
Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer. Br J Cancer (1995) 0.96
Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol (2001) 0.96
Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer. Genomics (1998) 0.95
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Eur J Hum Genet (2001) 0.95
Prognostic factors in well-differentiated early-stage epithelial ovarian cancer. Cancer (1993) 0.92
Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood. Int J Cancer (1991) 0.92
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res (1993) 0.92
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families. Br J Cancer (2000) 0.92
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet (1996) 0.91
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1. Genes Chromosomes Cancer (2000) 0.91
Changes in selected physiological and laboratory measurements in elite horses competing in a 160 km endurance ride. Equine Vet J Suppl (2006) 0.91
Quantitative analysis of the nuclear area variation in benign and malignant breast cytology specimens. Anal Quant Cytol (1981) 0.91
Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan. Cytometry (1994) 0.90
The relevance of morphometry in the differential diagnosis of cutaneous T cell lymphomas. Br J Dermatol (1981) 0.90
DNA image cytometry on machine-selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry. Cytometry (1985) 0.90
Morphometric characterization of diffuse large-cell (histiocytic) lymphomas. Am J Pathol (1982) 0.90
Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients. Clin Endocrinol (Oxf) (2011) 0.90
Genetics of human breast cancer. Cancer Surv (1990) 0.89
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes. Br J Cancer (1997) 0.88
Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Cytometry (1997) 0.88